Saudi Arabia Blood Glucose Device Market to Reach US$ 259.8 Million by 2033, Driven by Rising Diabetes Prevalence and Technological Innovation
According to the latest research analysis by Renub Research, the Saudi Arabia Blood Glucose Device Market is anticipated to increase from US$ 143.96 million in 2024 to US$ 259.8 million by 2033, registering a CAGR of 6.78% during the forecast period 2025–2033.
Increasing Diabetes Awareness, Government Initiatives, and Demand for Smart Monitoring Devices Fuel Market Growth
According to the latest research analysis by Renub Research, the Saudi Arabia Blood Glucose Device Market is anticipated to increase from US$ 143.96 million in 2024 to US$ 259.8 million by 2033, registering a CAGR of 6.78% during the forecast period 20252033. This growth is driven by the rising burden of diabetes, government-supported healthcare initiatives, and greater acceptance of self-monitoring technologies among the Saudi population.
? Explore the complete report: Saudi Arabia Blood Glucose Device Market - Renub Research
Rising Diabetes Prevalence is a Major Market Driver
Saudi Arabia has one of the highest rates of diabetes in the Middle East, with nearly 1 in 5 adults living with the condition. A combination of sedentary lifestyles, rising obesity, high sugar consumption, and genetic predisposition has exacerbated the prevalence of both Type 1 and Type 2 diabetes across the Kingdom.
This alarming trend has intensified the need for regular blood glucose monitoring, spurring the demand for advanced glucometers, continuous glucose monitoring (CGM) systems, testing strips, and lancets. Early diagnosis, routine tracking, and patient self-care are now central to diabetes management strategies in the country.
Government Initiatives and Vision 2030 Boost Healthcare Access
Under the Saudi Vision 2030 initiative, the government is aggressively transforming the healthcare system with the aim of creating a vibrant society by improving public health. Programs focused on non-communicable disease control, digital health, and preventive care have created an enabling environment for the blood glucose device market to thrive.
Efforts by the Ministry of Health (MoH) to integrate diabetes screening in primary healthcare centers, conduct public awareness campaigns, and distribute subsidized glucose monitors are making diagnosis and management more accessible across all income groups.
Technological Advancements Propel Market Growth
The Saudi market is witnessing rapid adoption of next-generation glucose monitoring systems such as continuous glucose monitors (CGMs), flash glucose monitors (FGMs), and smart insulin delivery devices. These innovations offer real-time glucose readings, minimal invasiveness, and mobile connectivityallowing patients to track blood sugar levels via smartphones and cloud-based apps.
This convenience and precision are especially appealing to younger diabetic patients, healthcare providers, and caregivers who seek accuracy in long-term glycemic control. Moreover, the introduction of AI-powered diagnostics and telemedicine support enhances treatment adherence and early intervention, thus driving market expansion.
Self-Monitoring Trends Accelerate Demand for Portable Devices
Increasing health awareness and the growing preference for at-home healthcare solutions have made self-monitoring of blood glucose (SMBG) a standard practice in Saudi households. As diabetic patients become more involved in their own care, the demand for compact, affordable, and easy-to-use glucose meters continues to surge.
Pharmacies, e-commerce platforms, and diagnostic clinics are all capitalizing on this shift by offering bundled diabetes care kits, monthly testing subscriptions, and device training programs tailored for patients and families.
Market Segmentation: CGM Devices Lead, Test Strips Hold Strong Share
By device type, continuous glucose monitoring (CGM) systems are expected to record the fastest growth due to their non-invasive design and real-time tracking features. However, blood glucose test strips remain a dominant revenue contributor, driven by their routine use and affordability.
Among end-users, the homecare segment leads the market, followed by hospitals, clinics, and diagnostic laboratories. The ease of operating modern glucometers has made them increasingly popular among the elderly and working professionals managing diabetes from home.
Strategic Collaborations and International Investment
Global players are actively investing in the Saudi market through distribution partnerships, product launches, and strategic collaborations with local healthcare providers. Companies such as Abbott, Roche, Medtronic, Dexcom, Ascensia Diabetes Care, and others are competing to expand their footprint by offering customized solutions for the Gulf region.
The influx of foreign direct investment (FDI) in the Kingdoms healthcare infrastructure, backed by favorable government regulations and public-private partnerships (PPPs), is expected to further boost product penetration and market competitiveness.
Challenges: High Device Costs and Limited Rural Awareness
Despite strong market growth, challenges such as the high cost of advanced monitoring devices, especially CGMs and insulin pumps, can limit access for lower-income and rural populations. Moreover, limited awareness about the importance of early diabetes detection and glucose monitoring in some remote regions may delay diagnosis and treatment.
To address this, stakeholders are increasingly working to launch educational initiatives, mobile diabetes clinics, and subsidized device programs aimed at improving public engagement and patient outreach across Saudi Arabia.
Future Outlook: Digital Integration and Preventive Care to Define Growth
The future of the Saudi blood glucose device market will be shaped by the integration of digital health solutions, such as cloud-based monitoring systems, AI-driven diagnostics, wearable sensors, and personalized diabetes care apps. These technologies will empower both patients and doctors with real-time insights, helping reduce complications and emergency hospital visits.
Additionally, with preventive care becoming a national healthcare priority, glucose monitoring devices are expected to become as commonplace as blood pressure monitors and thermometers in Saudi homes.
New Publish Report:
- Global Octopus Market Production by Countries, Import, Export, Value Chain Analysis & Forecast 2024-2030
- Global Online Travel Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
- Global Osteoporosis Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
About the Company
Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture. Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com
Website: www.renub.com